E2F1 inhibition mediates cell death of metastatic melanoma.

about

E2F1 inhibition mediates cell death of metastatic melanoma.

Item

http://www.wikidata.org/entity/Q55127548

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

E2F1 inhibition mediates cell death of metastatic melanoma.

@en

E2F1 inhibition mediates cell death of metastatic melanoma.

@nl

type

Item

label

E2F1 inhibition mediates cell death of metastatic melanoma.

@en

E2F1 inhibition mediates cell death of metastatic melanoma.

@nl

prefLabel

E2F1 inhibition mediates cell death of metastatic melanoma.

@en

E2F1 inhibition mediates cell death of metastatic melanoma.

@nl

P1476

E2F1 inhibition mediates cell death of metastatic melanoma.

@en

P2093

Alexandre Lebeau

http://www.w3.org/2001/XMLSchema#string

Corine Bertolotto

http://www.w3.org/2001/XMLSchema#string

Florian Rouaud

http://www.w3.org/2001/XMLSchema#string

Jean-Sébastien Annicotte

http://www.w3.org/2001/XMLSchema#string

Joséphine Zangari

http://www.w3.org/2001/XMLSchema#string

Mickaël Ohanna

http://www.w3.org/2001/XMLSchema#string

Nedra Hamouda-Tekaya

http://www.w3.org/2001/XMLSchema#string

Patricia Abbe

http://www.w3.org/2001/XMLSchema#string

Stéphane Rocchi

http://www.w3.org/2001/XMLSchema#string

Veronique Hofman

http://www.w3.org/2001/XMLSchema#string

P2860

Feedback between p21 and reactive oxygen production is necessary for cell senescence

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Increased gene copy number of the transcription factor E2F1 in malignant melanoma

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance

E2F1 in melanoma progression and metastasis

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.

P2888

s41419-018-0566-1

P304

527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-018-0566-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103886311

http://www.w3.org/2001/XMLSchema#string

P698

29743521

http://www.w3.org/2001/XMLSchema#string

P932

5943238

http://www.w3.org/2001/XMLSchema#string